# 68118-100-01 · Streptozocin Powder, For Solution · ESTEVE PHARMACEUTICALS, S.A. — FDA drug shortage duration tracker

For 68118-100-01 · Streptozocin Powder, For Solution · ESTEVE PHARMACEUTICALS, S.A., package ndc is 68118-100-01; generic name is Streptozocin Powder, For Solution; manufacturer is ESTEVE PHARMACEUTICALS, S.A; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 68118-100-01 _(verified: appears in the quote below)_
- **Generic name:** Streptozocin Powder, For Solution _(verified: appears in the quote below)_
- **Manufacturer:** ESTEVE PHARMACEUTICALS, S.A. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 07/12/2022 _(verified: appears in the quote below)_
- **Last update date:** 05/06/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1512 _(our reading, not quoted from the source)_
- **Dosage form:** Powder, For Solution _(verified: appears in its own passage below)_
- **Therapeutic category:** Oncology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "07/12/2022", "package_ndc": "68118-100-01", "generic_name": "Streptozocin Powder, For Solution", "related_info_link": "https://www.fda.gov/media/187353/download?attachment", "contact_info": "USSZTOrders@esteve.com", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "05/06/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Powder, For Solution", "presentation": "Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)", "company_name": "ESTEVE PHARMACEUTICALS, S.A.", "status": "Current"

### Status

> "update_date": "05/06/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Powder, For Solution", "presentation": "Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)", "company_name": "ESTEVE PHARMACEUTICALS, S.A.", "status": "Current"

### Last update date

> "update_date": "05/06/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Powder, For Solution", "presentation": "Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)", "company_name": "ESTEVE PHARMACEUTICALS, S.A.", "status": "Current"

### Dosage form

> "update_date": "05/06/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Powder, For Solution", "presentation": "Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)", "company_name": "ESTEVE PHARMACEUTICALS, S.A.", "status": "Current"

### Therapeutic category

> "update_date": "05/06/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Powder, For Solution", "presentation": "Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)", "company_name": "ESTEVE PHARMACEUTICALS, S.A.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22ESTEVE%20PHARMACEUTICALS,%20S.A.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).